News Quantified

MYGN – myriad genetics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer [Yahoo! Finance]

Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer

2 High-Flying Stocks with Competitive Advantages and 1 We Brush Off [Yahoo! Finance]

Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer [Yahoo! Finance]

3 Reasons to Sell MYGN and 1 Stock to Buy Instead [Yahoo! Finance]

1.1%

BEAT

-21.0%

BEAT

46.5%

BEAT

-44.1%

BEAT

Form 4 MYRIAD GENETICS INC For: Mar 13 Filed by: Haas Kevin Richard

Form 4 MYRIAD GENETICS INC For: Mar 12 Filed by: Donnelly Brian J

Form 4 MYRIAD GENETICS INC For: Mar 12 Filed by: Solaiman Shereen

Form 4 MYRIAD GENETICS INC For: Mar 12 Filed by: Muzzey Dale

Form 4 MYRIAD GENETICS INC For: Mar 12 Filed by: Fox Jennifer Lynne

Top News Gainers

8/1 Form 8-K MYRIAD GENETICS INC For: Aug 01 55.0%

4/6 Myriad Receives Reimbursement for the BRACAnalysis® Diagnostic System in Japan for Patients with Breast or Ovarian Cancer Associated with HBOC 25.2%

3/23 Myriad Announces Board of Directors Leadership Transition 12.5%

11/6 GeneSight® Psychotropic Test Improved Clinical Outcomes for People with Depression Who Were Taking Medications with Gene-Drug Interactions 11.5%

8/16 Myriad Genetics, Inc. (NASDAQ: MYGN) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.6%

12/4 Myriad’s Prequel™ Prenatal Screen has Superior Sensitivity in Women with High BMI Undergoing Non-Invasive Prenatal Screening 7.9%

3/25 Myriad Genetics, Inc. (NASDAQ: MYGN) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 7.1%

8/2 Myriad Genetics, Inc. (NASDAQ: MYGN) was upgraded by analysts at Bank of America Corp from an "underperform" rating to a "neutral" rating. 6.8%

11/23 DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. and Encourages Investors to Contact the Firm 6.4%

4/28 Myriad to Announce Fiscal Third-Quarter 2020 Financial Results on May 5, 2020 6.2%

Top News Decliners

8/13 Q4/2019 6/30/2019 EPS 0.410 ZacksConsensus 0.400 ActVsEst 0.010 - Beat -42.8%

11/4 Q1/2020 9/30/2019 EPS 0.080 ZacksConsensus 0.260 ActVsEst (0.180) - Miss -40.1%

2/6 Q2/2020 12/31/2019 EPS 0.230 ZacksConsensus 0.220 ActVsEst 0.010 - Beat -28.2%

5/7 Form 8-K MYRIAD GENETICS INC For: May 07 -21.4%

8/14 Myriad Genetics, Inc. (NASDAQ: MYGN) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating. -9.9%

8/22 Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related Cancer Prevention -8.1%

6/14 Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at Barclays PLC from $18.00 to $20.00. They now have an "underweight" rating on the stock. -7.7%

2/7 Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at Piper Sandler from to . -6.3%

3/17 Myriad Genetics, Inc. (NASDAQ: MYGN) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -6.0%

8/7 Myriad Will Seek FDA Approval of BRACAnalysis CDx® As a Companion Diagnostic for Lynparza® (olaparib) In Men with Metastatic Castrate-Resistant Prostate Cancer -4.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day